Adjunctive Metformin for Patients With Schizophrenia
A recent meta-analysis shows this agent is useful in the prevention and treatment of antipsychotic-induced weight gain.
Health Technology for Relapse Prevention in Schizophrenia
A “high-tech” approach to relapse prevention in patients with schizophrenia.
Research Findings That Can Change Clinical Practice: Part 1
Can't keep up with the literature? Here's some help.
Thank you, Drs. Ronald Pies and Joseph Pierre
With antipsychotics, my once-brilliant child can again speak, write, read, and maintain hygiene and has regained motor functioning.
Adjunctive Topiramate in People With Schizophrenia
A recent meta-analysis shows this adjunctive agent reduces residual symptoms of psychopathology as well as body weight.
Advances in Schizophrenia in 2016
The year 2016 marks a critical time in our understanding of and approaches to treating schizophrenia spectrum disorders.
Schizophrenia Risk From 8 to 18
Is inflammation a cause or consequence of illness in schizophrenia?
By clicking Accept, you agree to become a member of the UBM Medica Community.